Insider · CIK 0001738054

Patel Gautam

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001738054

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	AMRXAmneal Pharmaceuticals, Inc.A Award	Director	AAward	+284K sh	—	—	283,632
2026-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.8K sh	—	—	1,643,963
2026-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−34.8K sh	—	—	0
2026-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+19.8K sh	—	—	19,824
2025-12-12	SPBSpectrum Brands Holdings, Inc.A Award	Director	AAward	+4,602 sh	—	—	22,141
2025-06-16	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−94.9K sh	$8.02	−$761K	1,609,144
2025-06-10	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−56.4K sh	$8.02	−$453K	1,704,050
2025-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+34.8K sh	—	—	34,819
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−4,900 sh	$8.00	−$39.2K	1,720,218
2025-05-05	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+40.3K sh	—	—	1,760,476
2025-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−40.3K sh	—	—	0
2025-05-02	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−3,768 sh	$8.00	−$30.1K	1,725,118
2025-04-01	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−80K sh	$8.30	−$664K	1,728,886
2025-03-03	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−80K sh	$8.90	−$712K	1,808,886
2025-02-03	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−80K sh	$8.14	−$651K	1,888,886
2025-01-08	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−62.6K sh	$8.01	−$501K	1,968,886
2025-01-02	AMRXAmneal Pharmaceuticals, Inc.S Sale	Director	SSale	−17.4K sh	$8.01	−$139K	2,031,476
2024-11-19	SPBSpectrum Brands Holdings, Inc.A Award	Director	AAward	+2,770 sh	$90.26	+$250K	17,539
2024-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+76.5K sh	—	—	2,048,886
2024-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−76.5K sh	—	—	0
2024-05-02	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+40.3K sh	—	—	40,258
2024-01-01	AMRXAmneal Pharmaceuticals, Inc.J Other	Director	JOther	−33.5M sh	—	—	374,318
2024-01-01	AMRXAmneal Pharmaceuticals, Inc.G Gift	Director	GGift	+1.6M sh	—	—	1,972,433
2023-11-24	SPBSpectrum Brands Holdings, Inc.A Award	Director	AAward	+3,775 sh	—	—	14,769
2023-11-07	AMRXAmneal Pharmaceuticals, Inc.J Other	Director	JOther	+17.5M sh	—	—	30,384,769
2023-11-07	AMRXAmneal Pharmaceuticals, Inc. · Class B Common Stock and Common UnitsJ Other	Director	JOther	−17.5M sh	—	—	0
2023-05-10	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+80.1K sh	—	—	374,318
2023-05-10	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−80.1K sh	—	—	0
2023-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+76.5K sh	—	—	76,453
2022-11-25	SPBSpectrum Brands Holdings, Inc.A Award	Director	AAward	+5,020 sh	—	—	10,994
2022-05-09	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+80.1K sh	—	—	80,128
2022-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+35.4K sh	—	—	294,190
2022-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−35.4K sh	—	—	0
2021-12-17	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+50K sh	$4.21	+$211K	258,784
2021-12-15	SPBSpectrum Brands Holdings, Inc.A Award	Director	AAward	+2,441 sh	—	—	5,974
2021-12-01	AMRXAmneal Pharmaceuticals, Inc.J Other	Director	JOther	+3.07M sh	—	—	15,960,731
2021-05-06	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+46.2K sh	—	—	208,784
2021-05-06	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−46.2K sh	—	—	0
2021-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+35.4K sh	—	—	35,406
2020-12-22	SPBSpectrum Brands Holdings, Inc.A Award	Director	AAward	+3,533 sh	—	—	3,533
2020-05-07	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,459 sh	—	—	162,566
2020-05-07	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,459 sh	—	—	0
2020-05-05	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+46.2K sh	—	—	46,218
2020-03-03	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+118K sh	$3.94	+$464K	156,107
2020-03-02	AMRXAmneal Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+32.1K sh	$3.88	+$125K	38,218
2019-11-11	AMRXAmneal Pharmaceuticals, Inc.C Conversion	Director	CConversion	+12.9M sh	—	—	12,887,433
2019-11-11	AMRXAmneal Pharmaceuticals, Inc.J Other	Director	JOther	−12.9M sh	—	—	17,497,336
2019-11-11	AMRXAmneal Pharmaceuticals, Inc. · Common UnitsC Conversion	Director	CConversion	−12.9M sh	—	—	17,497,336
2019-05-08	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,107 sh	—	—	6,107
2019-05-08	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,107 sh	—	—	0

Recent filings

Accepted (ET)
Aug 124
Patel Gautam0001628280-26-056288
SEC(opens sec.gov)
May 84
Patel Gautam0001628280-26-032922
SEC(opens sec.gov)
Dec 164
Patel Gautam0001738054-25-000006
SEC(opens sec.gov)
Jun 184
Patel Gautam0001628280-25-032108
SEC(opens sec.gov)
Jun 124
Patel Gautam0001628280-25-030958
SEC(opens sec.gov)
May 84
Patel Gautam0001628280-25-023966
SEC(opens sec.gov)
May 64
Patel Gautam0001628280-25-022719
SEC(opens sec.gov)
Apr 24
Patel Gautam0001628280-25-016184
SEC(opens sec.gov)
Mar 54
Patel Gautam0001628280-25-010679
SEC(opens sec.gov)
Feb 54
Patel Gautam0001628280-25-004064
SEC(opens sec.gov)
Jan 104
Patel Gautam0001628280-25-001153
SEC(opens sec.gov)
Jan 64
Patel Gautam0001628280-25-000581
SEC(opens sec.gov)
Nov 204
Patel Gautam0000109177-24-000061
SEC(opens sec.gov)
May 144
Patel Gautam0001628280-24-023241
SEC(opens sec.gov)

Companies

Address

630 5TH AVENUE, 20TH FLOOR

NEW YORK, NY, 10111